Investigation Overview
December 26, 2014 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of bluebird bio Inc (NASDAQ:BLUE) shares was announced over potential breaches of fiduciary duties by certain officers and directors at bluebird bio.
The investigation by a law firm concerns whether certain bluebird bio officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
bluebird bio Inc reported that its annual Total Revenue rose from $0.34 million in 2012 to $20.18 million in 2013. Shares of bluebird bio Inc (NASDAQ:BLUE) grew from $17.69 per share in May 2014 to as high as $94.49 per share on December 15, 2014.
On December 26, 2014, NASDAQ:BLUE shares closed at $89.99 per share.